accepted and acknowledged
on 16 Feb 2023
Last Applicant/ Owned by
The Core, Bath Lane
Newcastle Upon Tyne
GB
NE4 5TF
Serial Number
86650167 filed on 03rd Jun 2015
Registration Number
5010851 registered on 02th Aug 2016
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Scientific and technological services and research and design relating thereto, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring s Read More
Scientific and technological services and research and design relating thereto, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific analysis and research services, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific analysis and research services using cell cultures and/or stem cells to define the action of novel therapeutics in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services for electrophysiology and related techniques to define the action of novel therapeutics in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services providing data on biological, organic and non-organic chemical potency, efficacy and mechanism of action at a native biological target in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services measuring biological, organic and non-organic chemical compound potency against biological targets coupled to their native transduction pathways and expressed with their naturally occurring subunit conformation and accessory proteins in the central nervous system, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services providing functional and mechanistic data on neural mechanisms that underlie higher brain functions, such as cognition, attention and sensory processing, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services to define the phenotype of transgenic models at the cellular and neuronal network level, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services to produce functional and mechanistic data on the physiological processes that may be affected in central nervous system disorders, such as the mechanisms underlying learning, memory, attention and sensory processing, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services for the provision of scientific functional and mechanistic data on neurophysiological diseases, including psychiatry, neurology, neurodegeneration, epilepsy, pain, ophthalmology and retinal neurodegeneration, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory, analysis and research services for the provision of scientific functional and mechanistic data on biological targets, including ligand and voltage gated ion channels, G-protein coupled receptors and biological transporters, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific laboratory services to discover and research the biological site of action of novel therapeutics within a cellular and neuronal network, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of assays using cell cultures and/or stem cells, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of electrophysiology and electrophysiological assays, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of laboratory equipment assays using cell cultures and/or stem cells and laboratory consumables therefor, namely, for testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; design and development of laboratory equipment for electrophysiology and electrophysiological assays and laboratory consumables therefor, namely, testing, screening and analysis of pharmaceuticals and naturally occurring substances, chemical screening and analysis, testing, screening and analysis of biological substances, performing pharmaceutical screening assays for others, evaluation of mechanisms of action of pharmaceuticals and naturally occurring substances, and identification of changes in biological functions in models of disease; scientific research consulting in the field of assays using and/or including cell cultures and/or stem cells; scientific research consulting in the field of electrophysiology and electrophysiological assays; scientific research consulting in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of educational and research project progression for all stages of the drug discovery process; scientific research consulting in the field of educational and research study plans in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of analysis and interpretation of experimental findings in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of the establishment and setting up of new laboratories; scientific research consulting in the field of the establishment and setting up of new laboratories using and/or including cell cultures and/or stem cells; scientific research consulting in the field of the establishment and setting up of new electrophysiology laboratories; scientific research consulting in the field of the design and development of assays for diseases and biological targets in the field of neurophysiology and neuropharmacology; scientific research consulting in the field of the preparation of data for the pharmaceutical industry; scientific research consulting in the field of the preparation of data for the pharmaceutical industry generated from cell cultures and/or stem cells; scientific research consulting in the field of the preparation of electrophysiological data for the pharmaceutical industry; scientific research consulting in the field of the design and development of assays for drug discovery; scientific research consulting in the field of the design and development of assays using and/or including cell cultures and/or stem cells for drug discovery; scientific research consulting in the field of the design and development of electrophysiology assays for drug discovery; scientific research consulting in the field of assays and tests to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; scientific research consulting in the field of assays and tests using and/or including cell cultures and/or stem cells to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; scientific research consulting in the field of electrophysiology and electrophysiological assays and tests to aid preclinical and clinical drug discovery programs, project progression, experimental plans and interpretation of data; scientific research consulting in the field of equipment purchase, and design and assembly of laboratories for in vitro and in vivo assays and tests; scientific research consulting in the field of equipment purchase, and design and assembly of laboratories using and/or including cell cultures and/or stem cells for in vitro assays and tests; scientific research consulting in the field of equipment purchase, and design and assembly of electrophysiology laboratories for in vitro and in vivo assays and tests; scientific research technology consulting services to the pharmaceutical industry on clinical and preclinical research in the fields of electrophysiology, neurophysiology and neuropharmacology; scientific research consulting services in neuroscience and translational research for disorders including neurology, neurodegeneration, psychiatry, epilepsy, pain and ophthalmology; scientific research technology consulting services providing guidance and experimental support for drug discovery research from target identification and validation through to candidate selection and progression to the clinic; scientific research consulting services on all applications of electrophysiology, including safety testing, drug screening, automated platforms and development of functional biomarkers
30th Jun 2013
30th Jun 2013
No 86650167
No Service Mark
No NEUR-001
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
16th Feb 2023 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
16th Feb 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
16th Feb 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
01st Aug 2022 | TEAS SECTION 8 & 15 RECEIVED |
02th Aug 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
02th Aug 2016 | REGISTERED-PRINCIPAL REGISTER |
17th May 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
17th May 2016 | PUBLISHED FOR OPPOSITION |
27th Apr 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
13th Apr 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |